Net profit of Concord Biotech declined 26.06% to Rs 44.06 crore in the quarter ended June 2025 as against Rs 59.59 crore during the previous quarter ended June 2024. Sales declined 5.47% to Rs 203.99 crore in the quarter ended June 2025 as against Rs 215.80 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 203.99 | 215.80 | -5 |
| OPM % | 30.10 | 37.66 | - |
| PBDT | 76.51 | 92.70 | -17 |
| PBT | 58.73 | 79.52 | -26 |
| NP | 44.06 | 59.59 | -26 |